References
Secondary hypertension and its treatment in cats

Abstract
Secondary hypertension caused by an underlying disease is common in older cats, especially in those with chronic kidney disease and/or hyperthyroidism. Systolic blood pressure should be measured whenever an associated disease is diagnosed and persistent systolic blood pressure >160mmHg should prompt treatment to prevent or reverse target organ damage. Amlodipine and telmisartan are licensed in the UK to treat feline hypertension and both drugs have been evaluated in prospective randomised placebo-controlled clinical trials in hypertensive cats with systolic blood pressure of 160–200mmHg that did not have evidence of target organ damage. Initial reductions of 20–30mmHg can be expected with either medication, and cats should be re-evaluated after 14 days and dose adjustments made as required. No studies have compared the performance of one drug against the other and either medication should be selected as the first-line treatment for feline hypertension. At present, there are more data in the literature to support the use of amlodipine in cats with severe hypertension (systolic blood pressure >200mmHg), or with evidence of ocular or neurological target organ damage.
There are three types of hypertension, or high blood pressure, in cats: primary (idiopathic), secondary and situational (previously referred to as ‘white coat’ hypertension). Secondary hypertension, which develops in association with an underlying disease process or because of a medication or toxin, is the most common type of hypertension in cats (Taylor et al, 2017; Acierno et al, 2018). The conditions typically associated with hypertension occur with increasing prevalence in older cats; therefore, the prevalence of secondary hypertension also increases with advancing age (Bijsmans et al, 2015; Conroy et al, 2018). The most common cause of hypertension in cats is chronic kidney disease (Maggio et al, 2000; Elliott et al, 2001; Sansom et al, 2004; Conroy et al, 2018). Other conditions associated with high rates of hypertension include hyperthyroidism (Elliott et al, 2001; Conroy et al, 2018), acute kidney injury (Cole et al, 2017) and hyperaldosteronism (although this condition is uncommon). Pheochromocytoma and Cushing's syndrome (Henry et al, 1993; Valentin et al, 2014) can also cause hypertension, but both are rare in this species. Cats with diabetes mellitus can be documented to have concurrent hypertension, but it is not clear that it occurs with a higher frequency than in the general cat population (Al-Ghazlat et al, 2011). Documentation of any of these conditions should prompt blood pressure measurement; details on performing these measurements and when to do so are covered elsewhere (Caney, 2021).
Register now to continue reading
Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.